相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteome screening of pleural effusions identifies ILIA as a diagnostic biomarker for non-small cell lung cancer
Yuanyuan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS
Dandan Xu et al.
PROTEOMICS (2015)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Identification of ENO1 As a Potential Sputum Biomarker for Early-Stage Lung Cancer by Shotgun Proteomics
Lei Yu et al.
CLINICAL LUNG CANCER (2014)
Plasma Proteome Database as a resource for proteomics research: 2014 update
Vishalakshi Nanjappa et al.
NUCLEIC ACIDS RESEARCH (2014)
Activities at the Universal Protein Resource (UniProt)
Rolf Apweiler et al.
NUCLEIC ACIDS RESEARCH (2014)
Evaluation of matrix metalloproteinase-2 in lung cancer
Randa Ali-Labib et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
Validation of a blood protein signature for non-small cell lung cancer
Michael R. Mehan et al.
CLINICAL PROTEOMICS (2014)
Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U. S. Preventive Services Task Force Recommendation
Linda L. Humphrey et al.
ANNALS OF INTERNAL MEDICINE (2013)
CK2 inhibitor CX4945 induces sequential inactivation of proteins in the signaling pathways related with cell migration and suppresses metastasis of A549 human lung cancer cells
Min Jeong Ku et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Identification of proteomic signatures associated with lung cancer and COPD
M. D. Pastor et al.
JOURNAL OF PROTEOMICS (2013)
Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
Daniel Ajona et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Development and Validation of a Plasma Biomarker Panel for Discerning Clinical Significance of Indeterminate Pulmonary Nodules
Shaun Daly et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Large-scale gene function analysis with the PANTHER classification system
Huaiyu Mi et al.
NATURE PROTOCOLS (2013)
Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer
Timothy R. Church et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2013)
Identification and Characterization of Angiogenesis Targets through Proteomic Profiling of Endothelial Cells in Human Cancer Tissues
Mehdi Mesri et al.
PLOS ONE (2013)
Overexpression of response gene to complement 32 (RGC32) promotes cell invasion and induces epithelial-mesenchymal transition in lung cancer cells via the NF-κB signaling pathway
Qinying Sun et al.
TUMOR BIOLOGY (2013)
Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers
Yasuhiro Hida et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules
Chad V. Pecot et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
The State of Molecular Biomarkers for the Early Detection of Lung Cancer
Mohamed Hassanein et al.
CANCER PREVENTION RESEARCH (2012)
A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening
William L. Bigbee et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Variant Ciz1 is a circulating biomarker for early-stage lung cancer
Gillian Higgins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of Novel Diagnostic Biomarkers for Asthma and Chronic Obstructive Pulmonary Disease
Nicole M. Verrills et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Lung Cancer Signatures in Plasma Based on Proteome Profiling of Mouse Tumor Models
Ayumu Taguchi et al.
CANCER CELL (2011)
Lung Cancer Serum Biomarker Discovery Using Label-Free Liquid Chromatography-Tandem Mass Spectrometry
Xuemei Zeng et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
Rachel M. Ostroff et al.
PLoS One (2011)
Lung Cancer Serum Biomarker Discovery Using Glycoprotein Capture and Liquid Chromatography Mass Spectrometry
Xuemei Zeng et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection
John Yee et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines
Chris Planque et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Secretory leukocyte peptidase inhibitor and lung cancer
Toshihiro Nukiwa et al.
CANCER SCIENCE (2008)
Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer
Macit Koldas et al.
CLINICAL LUNG CANCER (2008)
The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1
S. Nittka et al.
ONCOGENE (2008)
Panel of serum biomarkers for the diagnosis of lung cancer
Edward F. Patz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Reproducibility assessment of relative quantitation strategies for LC-MS based proteomics
Yeoun Jin Kim et al.
ANALYTICAL CHEMISTRY (2007)
The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway
T. Sugino et al.
JOURNAL OF PATHOLOGY (2007)
Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer
Ling-Jin Huang et al.
LUNG CANCER (2006)
Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells
RHM Salama et al.
CANCER LETTERS (2006)
Tissue factor pathway inhibitor: structure, biology and involvement in disease
BA Lwaleed et al.
JOURNAL OF PATHOLOGY (2006)
Mesothelin is shed from tumor cells
Mitchell Ho et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
An approach to studying lung cancer-related proteins in human blood
T Xiao et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry
YC Tyan et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Regularization and variable selection via the elastic net
H Zou et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2005)
Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment
C Jumper et al.
RESPIRATORY MEDICINE (2004)
Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway
XW Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis
BA Howard et al.
PROTEOMICS (2003)
Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry
H Zhang et al.
NATURE BIOTECHNOLOGY (2003)
Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells
N Devoogdt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Lung cancer screening with CT: Mayo Clinic experience
SJ Swensen et al.
RADIOLOGY (2003)
Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients
H Abe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
S Zucker et al.
ONCOGENE (2000)
Serum midkine levels are increased in patients with various types of carcinomas
S Ikematsu et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
